GLP-1 Agonists

Mazdutide

Catalog #: MDT

Mazdutide is a dual GLP-1/glucagon receptor agonist combining incretin and glucagon signaling for metabolic research. Enables study of concurrent appetite suppression and hepatic fat oxidation pathways.

Catalog Number MDT
Targets GLP-1 Receptor + Glucagon Receptor
Class Dual agonist peptide
Modification Fatty acid acylation

Available SKUs

Model Specification MOQ
MDT-10 10mg / 10ml 1 vial
Ships within 5-7 business days
Certificate of Analysis included
Quality guaranteed

Product Overview

Mazdutide is a dual GLP-1/glucagon receptor agonist combining incretin and glucagon signaling for metabolic research. Enables study of concurrent appetite suppression and hepatic fat oxidation pathways.

Research Applications

  • Dual GLP-1 and glucagon receptor agonist
  • GLP-1R: appetite suppression + insulin secretion
  • GcgR: hepatic fat oxidation + energy expenditure
  • Research focus on MASH/NAFLD paradigms
  • Fatty acid acylation for extended research duration

Key Features

  • ≥99% purity confirmed by RP-HPLC and ESI-MS
  • For laboratory research use only

Technical Support

Our team of product experts is available to assist with your research needs.

Contact Support

OEM Services

Need modifications or larger quantities? Request a custom synthesis quote.

Request Custom
Catalog Number MDT
Targets GLP-1 Receptor + Glucagon Receptor
Class Dual agonist peptide
Modification Fatty acid acylation
Form Lyophilized powder
Purity ≥99% (RP-HPLC)
Storage -20°C, desiccated

Need OEM or a Custom Configuration?

We support practical, production-ready customization for peptides, sequences, and modifications. Share your synthesizer type, dimensions, modifications preference, and packaging needs—our team will confirm feasibility and lead time.